Quotient

^{Priced, Nasdaq: QTNT}

Developing a diagnostics test for grouping and disease screening blood samples.

Industry: Health Care

First Day Return: -6.9%

QTNT

Developing a diagnostics test for grouping and disease screening blood samples.

IPO News for Quotient

It's not lupus: Exagen Diagnostics files for a $69 million IPO 09/22/14
Diagnostics developer T2 Biosystems files for a $69 million IPO 07/02/14
Quotient prices IPO at $8 04/24/14

IPO Data
IPO Date	04/24/2014
Offer Price	IPO Intelligence Only
Price Range	IPO Intelligence Only
Offer Shares (mm)	IPO Intelligence Only
Deal Size ($mm)	$40
Lock-Up Date	IPO Intelligence Only
Street Research	IPO Intelligence Only

Underwriters
IPO Intelligence Only

Company Data
Website www.quotientbd.com
Headquarters	Midlothian, United Kingdom
Founded	2007
Employees at IPO	170

IPO News for Quotient

It's not lupus: Exagen Diagnostics files for a $69 million IPO 09/22/14
Diagnostics developer T2 Biosystems files for a $69 million IPO 07/02/14
Quotient prices IPO at $8 04/24/14

Quotient (QTNT) Performance